Poor Profits: European Medtech Leaders Turn Less Optimistic
European medtech companies are anticipating lower profits in 2019 according to an industry survey by Simon-Kucher & Partners. The overall business expectations of respondents was significantly less optimistic than previous years due to a range of factors.
You may also be interested in...
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.